SE302126B - - Google Patents

Info

Publication number
SE302126B
SE302126B SE11790/62A SE1179062A SE302126B SE 302126 B SE302126 B SE 302126B SE 11790/62 A SE11790/62 A SE 11790/62A SE 1179062 A SE1179062 A SE 1179062A SE 302126 B SE302126 B SE 302126B
Authority
SE
Sweden
Application number
SE11790/62A
Inventor
E Reeder
L Sternbach
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US149527A external-priority patent/US3136815A/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE302126B publication Critical patent/SE302126B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/26—Preparation from compounds already containing the benzodiazepine skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE11790/62A 1961-11-02 1962-11-02 SE302126B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US149527A US3136815A (en) 1959-12-10 1961-11-02 Amino substituted benzophenone oximes and derivatives thereof

Publications (1)

Publication Number Publication Date
SE302126B true SE302126B (fr) 1968-07-08

Family

ID=22530691

Family Applications (2)

Application Number Title Priority Date Filing Date
SE11790/62A SE302126B (fr) 1961-11-02 1962-11-02
SE11789/62A SE301980B (fr) 1961-11-02 1962-11-02

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE11789/62A SE301980B (fr) 1961-11-02 1962-11-02

Country Status (8)

Country Link
BE (2) BE624169A (fr)
BR (1) BR6244259D0 (fr)
CH (2) CH420176A (fr)
DK (2) DK116287B (fr)
ES (2) ES282087A1 (fr)
FR (1) FR2979M (fr)
GB (2) GB988635A (fr)
SE (2) SE302126B (fr)

Also Published As

Publication number Publication date
DE1445866A1 (de) 1969-03-13
DK116287B (da) 1969-12-29
BE624168A (fr) 1963-04-29
ES282088A1 (es) 1963-03-16
CH420176A (de) 1966-09-15
BE624169A (fr) 1963-04-29
ES282087A1 (es) 1963-03-16
GB988634A (en) 1965-04-07
SE301980B (fr) 1968-07-01
CH420177A (de) 1966-09-15
FR2979M (fr) 1964-12-07
BR6244259D0 (pt) 1973-05-24
DE1445865A1 (de) 1969-03-13
DK116365B (da) 1970-01-05
GB988635A (en) 1965-04-07

Similar Documents

Publication Publication Date Title
BE601532A (fr)
BE493336A (fr)
BE472265A (fr)
BE475425A (fr)
BE599210A (fr)
BE601844A (fr)
BE625445A (fr)
BE601847A (fr)
BE601041A (fr)
BE601970A (fr)
BE599016A (fr)
BE618445A (fr)
BE601846A (fr)
BE475477A (fr)
BE598861A (fr)
BE164003A (fr)
BE482264A (fr)
BE600209A (fr)
BE616859A (fr)
BE601744A (fr)
BE600768A (fr)
BE626495A (fr)
SE301980B (fr)
BE600203A (fr)
BE583834A (fr)